Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Amodiaquine

Generic Name: Amodiaquine

Drug Type: Small Molecule

Chemical Formula: C_₂₀H_₂₂ClN_₃O

CAS Number: 86-42-0

Unique Ingredient Identifier: 220236ED28

Overview

A 4-aminoquinoquinoline compound with anti-inflammatory properties.

Background

A 4-aminoquinoquinoline compound with anti-inflammatory properties.

Indication

For treatment of acute malarial attacks in non-immune subjects.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.

Phase 3

Recruiting

Posted: 2019/04/23

Sponsor:University of Oxford

ID:NCT03923725

Phase 2 Efficacy Study of Primaquine and Methylene Blue

Phase 2

Completed

Posted: 2016/07/13

Sponsor:University of Califo...

ID:NCT02831023

Study of Artemether-lumefantrine, Amodiaquine and Primaquine in Healthy Subjects

Phase 1

Terminated

Posted: 2016/03/02

Sponsor:University of Oxford

ID:NCT02696954

A Trial of Seasonal Malaria Chemoprevention Plus Azithromycin in African Children

Phase 3

Completed

Posted: 2014/08/07

Sponsor:London School of Hyg...

ID:NCT02211729

Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With Malaria

Phase 2

Completed

Posted: 2013/10/07

Sponsor:National Institute o...

ID:NCT01955382

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy